CPRX earnings: real EPS beat/miss history, analyst consensus Buy, P/E 17.49. Updated 2026-07-23.
Catalyst Pharmaceuticals (CPRX) Research Hub
Catalyst Pharmaceuticals (CPRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-07-20, shares last closed at 31.49 USD (0.00%), in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. Valuation: trailing P/E 17.49, market cap 3.85B. This hub links to the full technical, earnings and options research available for CPRX.
Last updated 2026-07-20 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 31.49 USD (0.00%) |
| 52-week range | 19.05 USD – 32.56 USD |
| Trend regime | Uptrend |
| 14-day RSI | 60 (Bullish) |
| Trailing P/E | 17.49 |
| Market cap | 3.85B |
| Dividend yield | 0.00% |
Available research for CPRX
Covered Call on CPRX: how it works, illustrative setup around the real 31.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CPRX: how it works, illustrative setup around the real 31.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CPRX: how it works, illustrative setup around the real 31.49 USD price, max profit/loss, breakeven and when to use it. Educational.
CPRX technical analysis: uptrend, last 31.49 USD, RSI 60, 52w range 19.05 USD–32.56 USD, real support/resistance. Updated 2026-07-20.
Frequently asked questions
What sector is CPRX in?
Catalyst Pharmaceuticals (CPRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CPRX in an uptrend or downtrend?
As of 2026-07-20, CPRX is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. See the full technical research page for support and resistance levels.
What is CPRX's trailing P/E ratio?
CPRX's trailing P/E is 17.49, with a market cap of 3.85B. See the earnings research page for full valuation detail.